Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • P44 DETECTION OF SOLUBLE BCMA...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
P44 DETECTION OF SOLUBLE BCMA IN TEARS OF MM PATIENTS TREATED WITH BELANTAMAB MAFODOTIN

P44 DETECTION OF SOLUBLE BCMA IN TEARS OF MM PATIENTS TREATED WITH BELANTAMAB MAFODOTIN

Bibliographic Details
Main Authors: U. Munawar, J. Theuersbacher, L. Haertle, X. Zhou, S. Han, A. Regensburger, J. Mersi, M. Bittrich, F. Seifert, M.S. Haider, S. Nerreter, C. Vogt, E. Teufel, H. Einsele, L. Rasche, D. Kampik, K.M. Kortüm
Format: Article
Language:English
Published: Wiley 2023-05-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000936304.11663.09
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/01.HS9.0000936304.11663.09

Similar Items

  • Population pharmacokinetics of belantamab mafodotin, a BCMA‐targeting agent in patients with relapsed/refractory multiple myeloma
    by: Chetan Rathi, et al.
    Published: (2021-08-01)
  • Corneal epithelial changes in a patient treated with belantamab mafodotin
    by: Leandro Inferrera, et al.
    Published: (2023-01-01)
  • The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
    by: Melody R. Becnel, et al.
    Published: (2020-12-01)
  • Belantamab mafodotin associated corneal microcyst-like epithelial changes
    by: Katherine Chuang, et al.
    Published: (2022-03-01)
  • Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety
    by: Offidani M, et al.
    Published: (2021-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs